TITLE

Salmeterol/fluticasone of value for mild-to-moderate asthma

PUB. DATE
July 2007
SOURCE
PharmacoEconomics & Outcomes News;7/14/2007, Issue 532, p1
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article presents a study on salmeterol/fluticasone for treatment of mild to moderate asthma. According to the research, the most cost effective first-line controller therapy in mild to moderate asthma is salmeterol/fluticasone propionate compared to fluticasone inhaled corticosteroids (FPIC), nonfluticasone propionate inhaled corticosteroids (nFPIC) and leukotriene modifiers (LMs). The likelihoood of salmeterol/fluticasone, nFPIC and LMs being cost-effective were 98% as revealed in a sensitivty analyses.
ACCESSION #
26001114

 

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics